Palma, Shirlito V.
HRN: 27-82-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2025
CEFTRIAXONE 1G (VIAL)
09/23/2025
09/30/2025
IVTT
Q24H
OD
CAP
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines